Judith Clements
#106,450
Most Influential Person Now
Australian oncologist
Judith Clements's AcademicInfluence.com Rankings
Judith Clementsmedical Degrees
Medical
#1793
World Rank
#2169
Historical Rank
Oncology
#141
World Rank
#146
Historical Rank
Judith Clementsphilosophy Degrees
Philosophy
#6908
World Rank
#10029
Historical Rank
Logic
#3998
World Rank
#5237
Historical Rank
Download Badge
Medical Philosophy
Judith Clements's Degrees
- Masters Oncology University of Melbourne
- PhD Cancer Research University of Melbourne
Why Is Judith Clements Influential?
(Suggest an Edit or Addition)According to Wikipedia, Judith Ann Clements is an Australian academic and educator, specializing in Kallikrein proteases in prostate and ovarian cancers. Clements is the scientific director at the Australian Prostate Cancer Research Centre – Queensland and was head of the Cancer Research Program at the Institute of Health and Biomedical Innovation of Queensland University of Technology at the Translational Research Institute from 1997–2014.
Judith Clements's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Epithelial—mesenchymal and mesenchymal—epithelial transitions in carcinoma progression (2007) (1099)
- Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array (2012) (550)
- Bioengineered 3D platform to explore cell-ECM interactions and drug resistance of epithelial ovarian cancer cells. (2010) (543)
- Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (2018) (509)
- Identification of seven new prostate cancer susceptibility loci through a genome-wide association study (2009) (428)
- A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer (2014) (416)
- Clinical Pharmacokinetics of Paracetamol (1982) (414)
- Bioavailability, pharmacokinetics, and analgesic activity of ketamine in humans. (1982) (353)
- Pharmacokinetics and analgesic effect of ketamine in man. (1981) (307)
- Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study (2011) (295)
- Type II Transmembrane Serine Proteases (2001) (243)
- Studies on human sexual development. III. Fetal pituitary and serum, and amniotic fluid concentrations of LH, CG, and FSH. (1976) (241)
- The Tissue Kallikrein Family of Serine Proteases: Functional Roles in Human Disease and Potential as Clinical Biomarkers (2004) (222)
- Kallikreins on steroids: structure, function, and hormonal regulation of prostate-specific antigen and the extended kallikrein locus. (2010) (221)
- The glandular kallikrein family of enzymes: tissue-specific expression and hormonal regulation. (1989) (218)
- Can tissue engineering concepts advance tumor biology research? (2010) (218)
- Pro-opiomelanocortin messenger ribonucleic acid and posttranslational processing of beta endorphin in spleen macrophages. (1986) (217)
- Simplified radioimmunoassay for serum aldosterone utilizing increased antibody specificity. (1974) (214)
- PHARMACOKINETICS AND ANALGESIC EFFECTS OF I.M. AND ORAL KETAMINE (1981) (204)
- New nomenclature for the human tissue kallikrein gene family. (2000) (181)
- Pharmacokinetics and analgesic effects of i.m. and oral ketamine. (1982) (170)
- Glandular kallikreins and prostate-specific antigen are expressed in the human endometrium. (1994) (165)
- Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (163)
- The Potential Role of Lycopene for the Prevention and Therapy of Prostate Cancer: From Molecular Mechanisms to Clinical Evidence (2013) (157)
- Tissue-specific Expression Patterns and Fine Mapping of the Human Kallikrein (KLK) Locus on Proximal 19q13.4* (2000) (154)
- Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells. (2005) (149)
- Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. (2016) (146)
- Global Levels of Specific Histone Modifications and an Epigenetic Gene Signature Predict Prostate Cancer Progression and Development (2010) (145)
- The Expanded Human Kallikrein (KLK) Gene Family: Genomic Organisation, Tissue-Specific Expression and Potential Functions (2001) (145)
- Translating tissue engineering technology platforms into cancer research (2009) (144)
- Polygenic hazard score to guide screening for aggressive prostate cancer: development and validation in large scale cohorts (2018) (144)
- A comprehensive nomenclature for serine proteases with homology to tissue kallikreins (2006) (141)
- Candidate gene association studies: a comprehensive guide to useful in silico tools (2013) (140)
- Novel association of a diverse range of genes with renal cell carcinoma as identified by differential display (2000) (139)
- Ketamine disposition in children and adults. (1983) (137)
- Standard preanalytical coding for biospecimens: review and implementation of the Sample PREanalytical Code (SPREC). (2012) (135)
- Immuno- and bioactive inhibin and inhibin α-subunit expression in rat Leydig cell cultures (1989) (132)
- Kallikrein-related Peptidase 4 (KLK4) Initiates Intracellular Signaling via Protease-activated Receptors (PARs) (2008) (131)
- A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. (2013) (131)
- Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas. (2001) (130)
- Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers. (2003) (129)
- Enhancement of oxygen toxicity by the herbicide paraquat. (1973) (129)
- Type II Transmembrane Serine Proteases INSIGHTS INTO AN EMERGING CLASS OF CELL SURFACE PROTEOLYTIC ENZYMES* (2000) (124)
- Absorption, distribution and elimination of mexiletine. (1977) (119)
- Mineralized human primary osteoblast matrices as a model system to analyse interactions of prostate cancer cells with the bone microenvironment. (2010) (114)
- Substrate-guided design of a potent and selective kallikrein-related peptidase inhibitor for kallikrein 4. (2009) (113)
- Localization of a New Prostate-specific Antigen-related Serine Protease Gene, KLK4, Is Evidence for an Expanded Human Kallikrein Gene Family Cluster on Chromosome 19q13.3–13.4* (1999) (113)
- The human kallikrein gene family: a diversity of expression and function (1994) (104)
- Reactivation of embryonic nodal signaling is associated with tumor progression and promotes the growth of prostate cancer cells (2011) (104)
- Identification of a novel prostate cancer susceptibility variant in the KLK3 gene transcript (2011) (102)
- Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression (2013) (100)
- Expression analysis of δ‐catenin and prostate‐specific membrane antigen: Their potential as diagnostic markers for prostate cancer (2002) (96)
- Species-specific homing mechanisms of human prostate cancer metastasis in tissue engineered bone. (2014) (92)
- Glucocorticoid and mineralocorticoid effects on adrenocorticotropin and beta-endorphin in the adrenalectomized rat. (1982) (91)
- Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group. (2013) (90)
- Phenotypic Characterization of Prostate Cancer LNCaP Cells Cultured within a Bioengineered Microenvironment (2012) (83)
- Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants (2018) (83)
- Kallikrein-related peptidase 7 promotes multicellular aggregation via the alpha(5)beta(1) integrin pathway and paclitaxel chemoresistance in serous epithelial ovarian carcinoma. (2010) (82)
- The role of sulphate conjugation in the metabolism and disposition of oral and intravenous paracetamol in man. (1984) (81)
- 3D Cultures of Prostate Cancer Cells Cultured in a Novel High-Throughput Culture Platform Are More Resistant to Chemotherapeutics Compared to Cells Cultured in Monolayer (2014) (81)
- Androgen dependence of specific kallikrein gene family members expressed in rat prostate. (1988) (77)
- Characterization of a novel gene, STAG1/PMEPA1, upregulated in renal cell carcinoma and other solid tumors (2001) (77)
- The Molecular Biology of the Kallikreins and their Roles in Inflammation (1997) (75)
- Rapid and specific lowering of pituitary FSHβ mRNA levels by inhibin (1987) (74)
- Inhibin A-subunit gene expression in the ovaries of immature female rats is stimulated by pregnant mare serum gonadotrophin. (1986) (73)
- PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility. (2006) (72)
- Multiple novel prostate cancer susceptibility signals identified by fine-mapping of known risk loci among Europeans (2015) (71)
- Interactions between human osteoblasts and prostate cancer cells in a novel 3D in vitro model (2010) (69)
- Shared heritability and functional enrichment across six solid cancers (2018) (67)
- Arginine vasopressin (AVP) and AVP-like immunoreactivity in peripheral tissues. (1986) (67)
- The kallikrein-related peptidase family: Dysregulation and functions during cancer progression. (2016) (66)
- Risk Analysis of Prostate Cancer in PRACTICAL, a Multinational Consortium, Using 25 Known Prostate Cancer Susceptibility Loci (2015) (65)
- A common nomenclature for members of the tissue (glandular) kallikrein gene families. (1992) (65)
- Tissue engineered humanized bone supports human hematopoiesis in vivo. (2015) (65)
- A Plasma Biomarker Panel of Four MicroRNAs for the Diagnosis of Prostate Cancer (2018) (63)
- Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms. (2005) (63)
- Expression of PTRF in PC-3 Cells Modulates Cholesterol Dynamics and the Actin Cytoskeleton Impacting Secretion Pathways* (2011) (62)
- Seminal fluid characterization for male fertility and prostate cancer: kallikrein-related serine proteases and whole proteome approaches. (2007) (61)
- Pulmonary effects of paraquat in the first day after injection. (1975) (61)
- Post-GWAS in prostate cancer: from genetic association to biological contribution (2018) (61)
- The Microwell-mesh: A high-throughput 3D prostate cancer spheroid and drug-testing platform (2018) (60)
- Localization of arginine vasopressin-neurophysin II messenger ribonucleic acid in the hypothalamus of control and Brattleboro rats by hybridization histochemistry with a synthetic pentadecamer oligonucleotide probe. (1985) (58)
- Single nucleotide polymorphisms in clinics: Fantasy or reality for cancer?* (2015) (58)
- Kallikrein 4 is a potential mediator of cellular interactions between cancer cells and osteoblasts in metastatic prostate cancer (2007) (58)
- Studies on human sexual development. IV. Fetal pituitary and serum, and amniotic fluid concentrations of prolactin. (1977) (56)
- Prediction of individual genetic risk to prostate cancer using a polygenic score (2015) (56)
- Bioengineered 3 D platform to explore cell e ECM interactions and drug resistance of epithelial ovarian cancer cells (55)
- A comparison of the pharmacokinetics of propranolol in obese and normal volunteers. (1986) (55)
- Paracrine interactions between LNCaP prostate cancer cells and bioengineered bone in 3D in vitro culture reflect molecular changes during bone metastasis. (2014) (54)
- A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer. (2015) (54)
- Secretome and degradome profiling shows that Kallikrein‐related peptidases 4, 5, 6, and 7 induce TGFβ‐1 signaling in ovarian cancer cells (2013) (54)
- Kallikrein 4 (KLK4), a new member of the human kallikrein gene family is up-regulated by estrogen and progesterone in the human endometrial cancer cell line, KLE. (2001) (53)
- Growth of confined cancer spheroids: a combined experimental and mathematical modelling approach. (2013) (53)
- Paclitaxel Resistance and Multicellular Spheroid Formation Are Induced by Kallikrein-Related Peptidase 4 in Serous Ovarian Cancer Cells in an Ascites Mimicking Microenvironment (2013) (53)
- Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation (2016) (52)
- A bioengineered 3D ovarian cancer model for the assessment of peptidase-mediated enhancement of spheroid growth and intraperitoneal spread. (2013) (52)
- Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours. (1998) (52)
- A genetic variant of MDM4 influences regulation by multiple microRNAs in prostate cancer. (2015) (50)
- Estrogen regulation of kallikrein gene expression in the rat anterior pituitary. (1986) (49)
- Luteinizing hormone-beta mRNA levels are regulated primarily by gonadotropin-releasing hormone and not by negative estrogen feedback on the pituitary. (1988) (49)
- Emergence of MicroRNAs as Key Players in Cancer Cell Metabolism. (2019) (47)
- Coffee contains potent opiate receptor binding activity (1983) (47)
- Selective Substrates and Inhibitors for Kallikrein-Related Peptidase 7 (KLK7) Shed Light on KLK Proteolytic Activity in the Stratum Corneum. (2017) (45)
- Expression of the prolactin gene in human decidua-chorion. (1983) (45)
- Assays for Qualification and Quality Stratification of Clinical Biospecimens Used in Research: A Technical Report from the ISBER Biospecimen Science Working Group (2016) (44)
- MicroRNA Theranostics in Prostate Cancer Precision Medicine. (2016) (44)
- A humanized tissue-engineered in vivo model to dissect interactions between human prostate cancer cells and human bone (2014) (43)
- Humanised xenograft models of bone metastasis revisited: novel insights into species-specific mechanisms of cancer cell osteotropism (2013) (43)
- Kallikrein-related peptidase (KLK) family mRNA variants and protein isoforms in hormone-related cancers: do they have a function? (2006) (42)
- Engineered microenvironments provide new insights into ovarian and prostate cancer progression and drug responses. (2014) (42)
- Effects of dietary fiber. (1981) (41)
- The Cell Surface Glycoprotein CUB Domain-containing Protein 1 (CDCP1) Contributes to Epidermal Growth Factor Receptor-mediated Cell Migration* (2012) (41)
- Metastasis of ovarian cancer is mediated by kallikrein related peptidases (2013) (41)
- Prostatic trypsin-like kallikrein-related peptidases (KLKs) and other prostate-expressed tryptic proteinases as regulators of signalling via proteinase-activated receptors (PARs) (2008) (40)
- Pulmonary effects of the herbicide paraquat studied 3 days after injection in rats. (1973) (40)
- N-acetyl endorphin in rat spermatogonia and primary spermatocytes. (1985) (40)
- Kallikrein gene expression in human pituitary tissues (1996) (40)
- Immuno- and bioactive inhibin and inhibin alpha-subunit expression in rat Leydig cell cultures. (1989) (39)
- A variant of the KLK4 gene is expressed as a cis sense-antisense chimeric transcript in prostate cancer cells. (2010) (39)
- Molecular detection of prostate cells in ejaculate and urethral washings in men with suspected prostate cancer. (1999) (39)
- Fine-Mapping the HOXB Region Detects Common Variants Tagging a Rare Coding Allele: Evidence for Synthetic Association in Prostate Cancer (2014) (38)
- The role of kallikrein-related peptidases in prostate cancer: potential involvement in an epithelial to mesenchymal transition (2006) (38)
- Beyond the biomarker role: prostate-specific antigen (PSA) in the prostate cancer microenvironment (2019) (38)
- Tissue-specific developmental expression of the kallikrein gene family in the rat. (1990) (38)
- Germline variation at 8q24 and prostate cancer risk in men of European ancestry (2018) (37)
- Direct Progesterone Receptor and Indirect Androgen Receptor Interactions with the Kallikrein-Related Peptidase 4 Gene Promoter in Breast and Prostate Cancer (2009) (37)
- Lack of effect of ketamine analgesia on gastric emptying in man. (1981) (37)
- Common variation in Kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness. (2013) (36)
- Combined expression of KLK4, KLK5, KLK6, and KLK7 by ovarian cancer cells leads to decreased adhesion and paclitaxel-induced chemoresistance. (2012) (36)
- Delineating breast cancer cell interactions with engineered bone microenvironments (2013) (35)
- A 3D tumor microenvironment regulates cell proliferation, peritoneal growth and expression patterns. (2019) (35)
- Bone and prostate cancer cell interactions in metastatic prostate cancer (2007) (34)
- Kallikrein gene expression in the rat anterior pituitary (1985) (34)
- Concomitant dopaminergic and glucocorticoid control of pituitary proopiomelanocortin messenger ribonucleic acid and beta-endorphin levels. (1987) (34)
- Enter the Dragon: The Dynamic and Multifunctional Evolution of Anguimorpha Lizard Venoms (2017) (31)
- Lycopene reduces ovarian tumor growth and intraperitoneal metastatic load. (2017) (31)
- Tissue kallikrein and the bradykinin B2 receptor are expressed in endometrial and prostate cancers. (1997) (31)
- Glandular kallikrein gene expression in the human uterus. (1994) (31)
- Epithelial-Mesenchymal Transition in Prostate Cancer and the Potential Role of Kallikrein Serine Proteases (2007) (31)
- Genome-Wide Association Study of Prostate Cancer–Specific Survival (2015) (30)
- Vasopressin-neurophysin II gene expression in the ovary: studies in Sprague-Dawley, Long-Evans and Brattleboro rats. (1985) (28)
- Kallikrein 4 ( hK 4 ) and prostate-specific antigen ( PSA ) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition ( EMT )-like effect in prostate cancer cells (2005) (27)
- Genetic polymorphisms in the human tissue kallikrein (KLK) locus and their implication in various malignant and non-malignant diseases (2012) (27)
- Elevated plasma levels of pro-opiomelanocortin-derived peptides in sheep following hypothalamo-pituitary disconnection. (1986) (27)
- A Genetic Risk Score to Personalize Prostate Cancer Screening, Applied to Population Data (2019) (26)
- Activation of the kallikrein kinin system in interstitial cystitis. (1999) (26)
- Relationship between endogenous opioids and the oestrous cycle in the rat. (1984) (26)
- Kallikreins and kinins in inflammatory-like events in the reproductive tract. (1997) (26)
- Exploring the active site binding specificity of kallikrein-related peptidase 5 (KLK5) guides the design of new peptide substrates and inhibitors (2016) (26)
- Regulation of follicle-stimulating hormone β and common α-subunit messenger ribonucleic acid by gonadotropin-releasing hormone and estrogen in the sheep pituitary (1989) (26)
- Reflections on the tissue kallikrein and kallikrein-related peptidase family – from mice to men – what have we learnt in the last two decades? (2008) (26)
- Kallikrein gene family expression in the rat ovary: localization to the granulosa cell. (1995) (25)
- Glucocorticoid regulation of proopiomelanocortin gene expression in the pituitary gland of hypothalamopituitary intact and hypothalamopituitary disconnected sheep. (1989) (25)
- Human kallikrein 4 signal peptide induces cytotoxic T cell responses in healthy donors and prostate cancer patients (2012) (25)
- Mexiletine disposition: individual variation in response to urine acidification and alkalinisation. (1983) (25)
- Adipocytes promote prostate cancer stem cell self-renewal through amplification of the cholecystokinin autocrine loop (2015) (25)
- An integrative multi-omics analysis to identify candidate DNA methylation biomarkers related to prostate cancer risk (2020) (25)
- Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer (2018) (24)
- Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer (2018) (24)
- A re-evaluation of the tissue-specific pattern of expression of the rat kallikrein gene family. (1992) (24)
- Genetic Association of the KLK4 Locus with Risk of Prostate Cancer (2012) (23)
- Engineering osteoblastic metastases to delineate the adaptive response of androgen-deprived prostate cancer in the bone metastatic microenvironment (2019) (23)
- A novel transcript from the KLKP1 gene is androgen regulated, down‐regulated during prostate cancer progression and encodes the first non‐serine protease identified from the human kallikrein gene locus (2008) (23)
- Genetic Association of the KLK4 Locus with Risk of Prostate Cancer (2012) (23)
- Kallikrein-gene expression in the rat gastrointestinal tract. (1989) (23)
- Kallikrein gene expression in estrogen-induced pituitary tumors (1988) (22)
- Gamma-Tocotrienol Induces Apoptosis in Prostate Cancer Cells by Targeting the Ang-1/Tie-2 Signalling Pathway (2019) (22)
- Tie-2 regulates the stemness and metastatic properties of prostate cancer cells (2015) (21)
- Regulation of liver angiotensinogen mRNA by glucocorticoids and thyroxine (1989) (21)
- The oxygen dilemma. (1970) (21)
- Prostate Cancer-Associated Kallikrein-Related Peptidase 4 Activates Matrix Metalloproteinase-1 and Thrombospondin-1. (2016) (21)
- A Kallikrein 15 (KLK15) single nucleotide polymorphism located close to a novel exon shows evidence of association with poor ovarian cancer survival (2011) (20)
- Tissue-specific promoter utilisation of the kallikrein-related peptidase genes, KLK5 and KLK7, and cellular localisation of the encoded proteins suggest roles in exocrine pancreatic function (2008) (20)
- Using high throughput microtissue culture to study the difference in prostate cancer cell behavior and drug response in 2D and 3D co-cultures (2018) (20)
- Kallikrein-Related Peptidases in Prostate Cancer: From Molecular Function to Clinical Application (2014) (20)
- Ontogenesis of Gonadotropin-Releasing Hormone in the Human Fetal Hypothalamus (1980) (20)
- Tissue-specific Expression Patterns and Fine Mapping of the Human Kallikrein ( KLK ) Locus on Proximal 19 q 13 . 4 * (2000) (20)
- Kallikrein-Related Peptidase 10 (KLK10) Expression and Single Nucleotide Polymorphisms in Ovarian Cancer Survival (2010) (20)
- Bone marrow-derived stem/stromal cells (BMSC) 3D microtissues cultured in BMP-2 supplemented osteogenic induction medium are prone to adipogenesis (2018) (20)
- Adrenocorticotropin, β-Endorphin, and β-Mipotropin in Normal Thyroid and Lung: Possible Implications for Ectopic Hormone Secretion (1982) (19)
- Naloxone, adrenalectomy, and steroid replacement: evidence against a role for circulating beta-endorphin in food intake. (1981) (19)
- The Use of Predictive or Prognostic Genetic Biomarkers in Endometrial and Other Hormone-Related Cancers: Justification for Extensive Candidate Gene Single Nucleotide Polymorphism Studies of the Matrix Metalloproteinase Family and their Inhibitors (2009) (19)
- PITX2 and non-canonical Wnt pathway interaction in metastatic prostate cancer (2014) (18)
- Genomic analysis of male puberty timing highlights shared genetic basis with hair colour and lifespan (2020) (18)
- Genomic analysis of male puberty timing highlights shared genetic basis with hair colour and lifespan (2020) (18)
- Microenvironment engineering of osteoblastic bone metastases reveals osteomimicry of patient-derived prostate cancer xenografts. (2019) (18)
- Analysis of androgen and anti-androgen regulation of KLK-related peptidase 2, 3, and 4 alternative transcripts in prostate cancer (2014) (18)
- Pericellular regulation of prostate cancer expressed kallikrein-related peptidases and matrix metalloproteinases by cell surface serine proteases. (2017) (17)
- The kallikrein 14 gene is down-regulated by androgen receptor signalling and harbours genetic variation that is associated with prostate tumour aggressiveness (2012) (17)
- Breast Cancer Cells Induce Osteolytic Bone Lesions In vivo through a Reduction in Osteoblast Activity in Mice (2013) (17)
- Foot Shock Analgesia (1982) (16)
- Correlation of the expression of human kallikrein‐related peptidases 4 and 7 with the prognosis in oral squamous cell carcinoma (2011) (16)
- Selective cleavage of human sex hormone-binding globulin by kallikrein-related peptidases and effects on androgen action in LNCaP prostate cancer cells. (2012) (16)
- Circulating Metabolic Biomarkers of Screen-Detected Prostate Cancer in the ProtecT Study (2018) (16)
- Fusion transcript loci share many genomic features with non-fusion loci (2015) (16)
- Kallikrein‐related peptidase 4 induces cancer‐associated fibroblast features in prostate‐derived stromal cells (2017) (16)
- Association between Prostinogen (KLK15) Genetic Variants and Prostate Cancer Risk and Aggressiveness in Australia and a Meta-Analysis of GWAS Data (2011) (15)
- The Expression of the Kallikrein Gene Family in the Rat Pituitary: Oestrogen Effects and the Expression of an Additional Family Member in the Neurointermediate Lobe (1989) (15)
- A replication study examining novel common single nucleotide polymorphisms identified through a prostate cancer genome-wide association study in a Japanese population. (2011) (15)
- Effects of bromocriptine on blood pressure and plasma beta-endorphin in spontaneously hypertensive rats. (1981) (15)
- Functional Balance between TCF21-Slug defines phenotypic plasticity and sub-classes in high-grade serous ovarian cancer (2018) (15)
- Remodelling of the tumour microenvironment by the kallikrein-related peptidases (2022) (15)
- Prostate Cancer Risk-Associated Single-Nucleotide Polymorphism Affects Prostate-Specific Antigen Glycosylation and Its Function. (2019) (15)
- Localization of Bradykinin B2 Receptors in the Endometrium and Myometrium of Rat Uterus and the Effects of Estrogen and Progesterone. (1999) (14)
- Tissue-specific regulation of the expression of rat kallikrein gene family members by thyroid hormone. (1990) (14)
- Integration of Two In-depth Quantitative Proteomics Approaches Determines the Kallikrein-related Peptidase 7 (KLK7) Degradome in Ovarian Cancer Cell Secretome* (2019) (14)
- Long terminal repeats act as androgen-responsive enhancers for the PSA-kallikrein locus. (2012) (14)
- Expression of the renal kallikrein gene in mineralocorticoid-treated and genetically hypertensive rats. (1986) (14)
- Comparative Biomarker Expression and RNA Integrity in Biospecimens Derived from Radical Retropubic and Robot-Assisted Laparoscopic Prostatectomies (2010) (14)
- Standard PREanalytical Code version 3.0. (2018) (13)
- INSULIN HYPOGLYCAEMIA AND CHOLINERGIC BLOCKADE: RESPONSE OF PLASMA IMMUNOREACTIVE β‐ENDORPHIN (1983) (13)
- Development of anti-hLH antibodies after therapy with posterior pituitary extract. (1978) (13)
- A Suite of Activity-Based Probes To Dissect the KLK Activome in Drug-Resistant Prostate Cancer (2021) (12)
- The effect of sample size on polygenic hazard models for prostate cancer (2019) (12)
- Proteomic and other analyses to determine the functional consequences of deregulated kallikrein‐related peptidase (KLK) expression in prostate and ovarian cancer (2014) (12)
- Oestrogen administration and the expression of the kallikrein gene family in the rat submandibular gland. (1990) (12)
- MicroRNA-3162-5p-Mediated Crosstalk between Kallikrein Family Members Including Prostate-Specific Antigen in Prostate Cancer. (2019) (12)
- Hydrogel Microwell Arrays Allow the Assessment of Protease-Associated Enhancement of Cancer Cell Aggregation and Survival (2013) (12)
- A microsatellite repeat in PCA3 long non-coding RNA is associated with prostate cancer risk and aggressiveness (2017) (12)
- Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (2019) (11)
- Association Analysis of a Microsatellite Repeat in the TRIB1 Gene With Prostate Cancer Risk, Aggressiveness and Survival (2018) (11)
- Arginine vasopressin and oxytocin in organs outside the nervous system (1988) (11)
- Activation of membrane-bound proteins and receptor systems: a link between tissue kallikrein and the KLK-related peptidases (2014) (11)
- Murine, but not human, ephrin-B2 can be efficiently cleaved by the serine protease kallikrein-4: implications for xenograft models of human prostate cancer. (2015) (11)
- Expression of PSA-RP2, an alternatively spliced variant from the PSA gene, is increased in prostate cancer tissues but the protein is not secreted from prostate cancer cells (2010) (10)
- Effect of ethane dimethane sulphonate on proopiomelanocortin (POMC) mRNA and POMC-derived peptides in the rat testis (1989) (10)
- The molecular function of kallikrein‐related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer (2019) (10)
- Current perspectives on the molecular biology of the renal tissue kallikrein gene and the related tissue kallikrein gene family. (1998) (10)
- Humanization of the Prostate Microenvironment Reduces Homing of PC3 Prostate Cancer Cells to Human Tissue-Engineered Bone (2018) (10)
- Kallikrein-Related Peptidase 3 (KLK3/PSA) Single Nucleotide Polymorphisms and Ovarian Cancer Survival (2011) (9)
- In vitro engineering of a bone metastases model allows for study of the effects of antiandrogen therapies in advanced prostate cancer (2021) (9)
- Gene and pathway level analyses of germline DNA-repair gene variants and prostate cancer susceptibility using the iCOGS-genotyping array (2016) (9)
- Hormone-dependent cancers: new approaches to identification of potential diagnostic and/or therapeutic biomarkers (2010) (9)
- SWATH-MS Based Proteomic Profiling of Prostate Cancer Cells Reveals Adaptive Molecular Mechanisms in Response to Anti-Androgen Therapy (2021) (8)
- Rapid and specific lowering of pituitary FSH beta mRNA levels by inhibin. (1987) (8)
- In vitro evidence that KLK14 regulates the components of the HGF/Met axis, pro-HGF and HGF-activator inhibitor 1A and 1B (2016) (8)
- Localization of bradykinin B2 receptors in the endometrium and myometrium of rat uterus and the effects of estrogen and progesterone. (1999) (8)
- Mass spectrometry-based determination of Kallikrein-related peptidase 7 (KLK7) cleavage preferences and subsite dependency (2017) (7)
- Lycopene's Effects on Cancer Cell Functions within Monolayer and Spheroid Cultures (2016) (7)
- Production and characterization of antipeptide kallikrein 4 antibodies. Use of computer modeling to design peptides specific to Kallikrein 4. (2003) (7)
- The disposition of intravenous doxapram in man (2004) (7)
- Androgen receptor expression in primary prostate cancers of lobund-wistar rats and in tumor-derived cell lines (1999) (7)
- Paracetamol pharmacokinetics in thyroid disease (1980) (7)
- Opiate binding sites in bovine adrenal medulla. (1983) (7)
- Regulation of follicle-stimulating hormone beta and common alpha-subunit messenger ribonucleic acid by gonadotropin-releasing hormone and estrogen in the sheep pituitary. (1989) (7)
- N-Acetylated endorphins in ovine anterior pituitary and neuro-intermediate lobe (1987) (6)
- Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium (2017) (6)
- Constraints to counting bioluminescence producing cells by a commonly used transgene promoter and its implications for experimental design (2019) (5)
- Post-translational processing of pro-opiomelanocortin in the Brattleboro (di/di) rat pituitary. (1988) (5)
- Correction: 3D Cultures of Prostate Cancer Cells Cultured in a Novel High-Throughput Culture Platform Are More Resistant to Chemotherapeutics Compared to Cells Cultured in Monolayer (2015) (5)
- Transforming the future of treatment for ovarian cancer (2014) (5)
- Tissue Kallikrein–Kinin System (2011) (5)
- A variant of the KLK 4 gene is expressed as a cis sense – antisense chimeric transcript in prostate cancer cells (2010) (5)
- The tissue kallikrein gene cluster (2004) (5)
- Allele-Specific MicroRNA-Mediated Regulation of a Glycolysis Gatekeeper PDK1 in Cancer Metabolism (2021) (5)
- Single Nucleotide Polymorphisms (SNPs) (2014) (5)
- Realizing the potential of ejaculate/seminal fluid in detecting and predicting natural history. (2003) (5)
- Studies on regulation of gonadotropin gene expression in the hypothalamo-pituitary intact and hypothalamo-pituitary disconnected ewe (1990) (5)
- Mining human cancer datasets for kallikrein expression in cancer: the ‘KLK-CANMAP’ Shiny web tool (2018) (5)
- Pro-opiomelanocortin (POMC) gene expression, as identified by in situ hybridization, in purified populations of interstitial macrophages and Leydig cells of the adult rat testis. (1993) (4)
- STRESS, DOPAMINERGIC BLOCKADE AND MEDIAN EMINENCE‐NEUROINTERMEDIATE LOBE CATECHOLAMINE DEPLETION: EFFECTS ON HYPOTHALAMIC, PITUITARY AND PLASMA IMMUNOREACTIVE β‐ENDORPHIN (1984) (4)
- KLK4 Induces Anti-Tumor Effects in Human Xenograft Mouse Models of Orthotopic and Metastatic Prostate Cancer (2020) (4)
- Genetic Association of the KLK 4 Locus with Risk of Prostate Cancer (2012) (4)
- Publisher Correction: Shared heritability and functional enrichment across six solid cancers (2019) (4)
- Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma (2019) (4)
- Cellular model systems to study the tumor biological role of kallikrein-related peptidases in ovarian and prostate cancer (2012) (4)
- Candidate gene association studies: a comprehensive guide to useful in silicotools (2013) (4)
- Association between single-nucleotide polymorphisms in growth factor genes and quality of life in men with prostate cancer and the general population (2015) (4)
- Determination of pipothiazine in human plasma by reversed-phase high-performance liquid chromatography. (1989) (4)
- Tissue kallikrein in pituitary and brain (1990) (4)
- KLK3 SNP–SNP interactions for prediction of prostate cancer aggressiveness (2021) (4)
- Pituitary peptides in the ovary and testis (1988) (3)
- A computational analysis of the genetic and transcript diversity at the kallikrein locus (2016) (3)
- Gonadal steroids and anterior lobe dynorphin in the male rat. (1989) (3)
- Preparation of mineralised matrices secreted from human primary osteoblasts for analysis of the interaction of cancer cells and the bone microenvironment (2008) (3)
- Foot shock analgesia. Lack of correlation with pituitary and plasma immunoreactive-beta-endorphin. (1982) (3)
- Erratum to: Fusion transcript loci share many genomic features with non-fusion loci (2016) (3)
- Studies on mineralocorticoid receptors, B-endorphin, and thymocytes: Towards a redefinition of ’mineralocorticoid hormone' (1982) (3)
- Kallikrein-Related Peptidase 7 Promotes Multicellular Aggregation via the α 5 β 1 Integrin Pathway and Paclitaxel Chemoresistance in Serous Epithelial Ovarian Carcinoma (2010) (3)
- Interactions between the seminiferous tubules and Leydig cells of the testis. (1990) (3)
- Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (2019) (3)
- A genetic risk score to guide age-specific, personalized prostate cancer screening (2016) (3)
- Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (3)
- Determining Protease Substrates Within a Complex Protein Background Using the PROtein TOpography and Migration Analysis Platform (PROTOMAP). (2017) (2)
- Expression of the gene for arginine vasopressin in Brattleboro rats. (1984) (2)
- Re: Malignant cytological washings from radical prostatectomy specimens: a possible mechanism for local recurrence of prostate cancer following surgical treatment of organ confined disease. (1997) (2)
- Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (2)
- Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium (2017) (2)
- The roles of proteases in prostate cancer (2023) (2)
- Adrenocorticotropin, beta-endorphin, and beta-lipotropin in normal thyroid and lung: possible implications for ectopic hormone secretion. (1982) (2)
- A physiologically-based pharmacokinetic model for absorption of oral paracetamol in man [proceedings]. (1978) (2)
- The human tissue kallikrein and kallikrein-related peptidase family (2013) (2)
- New Nomenclature for the Human Tissue Kallikrein (2000) (2)
- Author Correction: Large-scale transcriptome-wide association study identifies new prostate cancer risk regions (2019) (2)
- Preface to “Proteases in Cancer Progression and Metastasis” special issue (2019) (1)
- A humanized tissue-engineered in vivo model to dissect interactions between human prostate cancer cells and human bone (2014) (1)
- An advanced bioengineered 3D model mimicking prostate cancer-induced bone metastasis microenvironment (Conference Abstract) (2016) (1)
- Pulmonary and circulatory effects of human fibrinopeptides. (1971) (1)
- Mass spectrometry based proteomics analyses in kallikrein-related peptidase research: implications for cancer research and therapy (2017) (1)
- Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer (2018) (1)
- Author Correction: Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility (2019) (1)
- A humanized orthotopic tumor microenvironment alters the bone metastatic tropism of prostate cancer cells (2021) (1)
- A 3D in vitro model reflecting the androgen deprivation state in prostate cancer bone metastasis (2015) (1)
- Integration of Two In-depth Quantitative Proteomics Approaches Determines the Kallikrein-related Peptidase 7 (KLK7) Degradome in Ovarian Cancer Cell Secretome. (2019) (1)
- Immunoreactive beta-endorphin levels in plasma and pituitary tissue from genetically hypertensive and normotensive rats. (1981) (1)
- Prostate cancer risk associated Single Nucleotide Polymorphism affects PSA glycosylation and its function (2019) (1)
- PSA and Kallikrein 4 expression in PC3 prostate cancer cells leads to a loss of cell adhesion molecules and an epithelial-mesenchymal transition (EMT) (2006) (1)
- 8 Australian prostate cancer collaboration (APCC) bioresource (2006) (1)
- Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants (2018) (1)
- Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia (2018) (1)
- Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma (2018) (1)
- Tissue engineered human primary osteoblast matrices and scaffold/hOsteoblast constructs applied to tumour/bone microenvironment research (2008) (0)
- A genetic hazard score to personalize prostate cancer screening, applied to population data (2019) (0)
- Gonadal neuropeptides: Studies in the pregnant, lactating and neonatal rat (1992) (0)
- THE DEVELOPMENTALLY REGULATED NOTCH 3 GENE AND THE SIGNAL TRANSDUCTION GENE, RGS-5, ARE UP REGULATED IN RENAL CELL CARCINOMA (1999) (0)
- Prostate specific antigen and E-cadherin in prostate cancer (2003) (0)
- Novel protease mediated mechanisms promote the spread of cancer cells via the blood circulation (2013) (0)
- Molecular mass analyses: limitations in discriminating healthy from diseased samples in prostate cancer (2005) (0)
- Number 10 / 54 Modeling the growth of multicellular cancer spheroids in a bioengineered 3 D microenvironment and their treatment with an anti-cancer drug by (2010) (0)
- Author Correction: Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility (2019) (0)
- Implication of 3D culture system for study of prostate cancer (CaP) mediated bone metastasis (2009) (0)
- Growth of confined cancer spheroids : a combined experimental marker, critical modelling approach (2013) (0)
- Characterisation of novel primary tumour derived epithelial prostate cancer cell lines (2015) (0)
- 251 Kallikrein-related Peptidase 4 and Prostate Cancer – an Extended Role in Tumour Progression (2012) (0)
- KALLIKREIN RELATED PROTEASES AND WNT PATHWAY INTERACTIONS IN PROSTATE CANCER (2008) (0)
- 16 Kallikrein 15 (KLK15) in prostate cancer: in silico analysis and single nucleotide polymorphism verification (2006) (0)
- Kallikrein and bradykinin receptor gene expression in normal and interstitial cystitis bladder (1997) (0)
- Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia (2019) (0)
- Kallikrein Related Proteases and Wnt Pathway Interactions (2008) (0)
- 523: Identification of kallikrein-related peptidase 7 degradome and transcriptome targets in ovarian cancer (2014) (0)
- Kallikrein 4 expression in mouse ovaries with inclusion cysts. (2006) (0)
- KLK7 (kallikrein-related peptidase 7) (2010) (0)
- Abstract A73: A bioengineered ovarian cancer microenvironment to assess protease-associated functions (2013) (0)
- 96. The PSA-related kallikrein enzymes and hormone-dependent cancers (2003) (0)
- Modeling the growth of multicellular cancer spheroids in abioengineered 3D microenvironment and their treatment with ananti-cancer drug (2010) (0)
- Subject Index Vol. 44, 1986 (1986) (0)
- Patient & control ejaculates contain psa +ve cells (1997) (0)
- Abstract 2842: Gene expression and genetic variation of the matrix metalloproteinase family: evidence for association with endometrial cancer risk and prognosis (2010) (0)
- 103: The tumour–stroma niche of ovarian cancer in 3D (2014) (0)
- Rethinking stromal cells contribution in the drug screening approach of prostate cancer (2015) (0)
- Highlight: proteolytic networks across cellular boundaries (2016) (0)
- Expression of prostate-specific antigen variant MRNA transcripts in prostate cancer and benign prostatic hyperplasia (2001) (0)
- Over-expression of hk7 in Head and Neck Squamous Cell Carcinoma – Potential Diagnostic and Prognostic Value (2007) (0)
- Relationship between geographic remoteness and socioeconomic status and PSA testing in Queensland (2007) (0)
- Putative cancer specific variants of PSA and the related kallikreins, K1, K2 are also expressed in Benign prostatic hyperplasia (1999) (0)
- Translational Science (2016) (0)
- The endocrinology of the neural peptides (1983) (0)
- VEGF expression in prostatic tissue (1999) (0)
- 142: Proteolytic regulation of the EphB4 receptor in prostate cancer (2014) (0)
- Kallikrein-related peptidase 4 induces tumour microenvironment alterations that support tumour growth (2015) (0)
- Erratum to: Fusion transcript loci share many genomic features with non-fusion loci (2016) (0)
- Metastasis of ovarian cancer is mediated by kallikrein related peptidases (2013) (0)
- Genomic analysis of male puberty timing highlights shared genetic basis with hair colour and lifespan (2020) (0)
- KLK4 (kallikrein-related peptidase 4) (2009) (0)
- Fine-mapping identifies multiple prostate cancer risk loci on 5p15 some associating with TERT expression (2013) (0)
- A prostate cancer risk associated polymorphism regulates androgen mediated regulation of a novel long noncoding RNA, IRX4lncRNA (2016) (0)
- Prostate cancer metastasis, the noncanonical Wnt pathway, and the transcription factor PITX2. (2010) (0)
- Reactivationof EmbryonicNodal Signaling Is AssociatedWithTumorProgression andPromotes the Growthof ProstateCancerCells (2011) (0)
- The effect of sample size on polygenic hazard models for prostate cancer (2020) (0)
- Highlight: Remodelling the KLK landscape down under (Editorial) (2016) (0)
- Single nucleotide polymorphisms in the KLK locus and their implication in various diseases (2012) (0)
- Human Tissue Kallikreins-Is Their Function Solely Proteolytic ? (2004) (0)
- A GWAS identified functional variation in PSA (KLK3) gene that confers lower risk is also associated with more aggressive disease and lower survival in men with prostate cancer (2019) (0)
- Cell-specific expression of POMC in the adult rat testicular interstitium (1992) (0)
- Molecular detection of PSA, PSMA and apolipoprotein D in ejaculate and urethral washings (1999) (0)
- Humanised xenograft models of bone metastasis revisited: novel insights into species-specific mechanisms of cancer cell osteotropism (2013) (0)
- The Microwell-mesh: A high-throughput 3D prostate cancer spheroid and drug-testing platform (2018) (0)
- 009. KALLIKREIN-RELATED PROTEASES AS NOVEL THERAPEUTIC TARGETS IN PROSTATE AND OVARIAN CANCER (2009) (0)
- Mass spectrometry-based determination of Kallikrein-related peptidase 7 (KLK7) cleavage preferences and subsite dependency (2017) (0)
- ID: 372 Kallikrein-related (KLK) serine proteases and their roles in prostate cancer: nuclear, cytoplasmic and secreted forms. (2006) (0)
- Highlight: remodelling the KLK landscape down under (2016) (0)
- Bone and Prostate Cancer Cell Interactions in Metastatic Disease. (2007) (0)
- bal Levels of Specific Histone Modifications and an enetic Gene Signature Predict Prostate Cancer B & P gression and Development (2010) (0)
- Translational Science (2018) (0)
- Fusion transcript loci share many genomic features with non-fusion loci (2015) (0)
- 554 INCREMENTAL EXPRESSION OF PITX2, A WNT PATHWAY ASSOCIATED TRANSCRIPTION FACTOR IN PRIMARY AND METASTATIC PROSTATE CANCER (2010) (0)
- Emergence of miRNAs as Key Players in Cancer Cell Metabolism (2021) (0)
- 113 Unravelling the Tumour-stroma Microenvironment of Late Stage Ovarian Cancer (2012) (0)
- The EphB4 receptor and its ligand, ephrinB2, are primary substrates for the serine protease kallikrein 4 - all key regulators of epithelial cancer progression (2010) (0)
- Manfred Schmitt (1947–2018) (2018) (0)
- Modulation of protease expression in prostate cancer cells after androgen deprivation (2015) (0)
- of sample on polygenic hazard models for prostate cancer. (2020) (0)
- 278: The kallikrein-related serine peptidase, KLK4, regulates the TGFb1 pathway in the tumour–stroma microenvironment in prostate cancer (2014) (0)
- A Multiple Nucleotide Length Polymorphism (MNLP) mediates androgen regulation of IRX4 in prostate cancer (2015) (0)
- Highly specific radioimmunoassay for serum aldosterone requiring no chromatographic separation (1974) (0)
- 10/10/2021 7:17:32 PM (2021) (0)
- Post-GWAS in prostate cancer: from genetic association to biological contribution (2018) (0)
- Germline variation at 8q24 and prostate cancer risk in men of European ancestry (2018) (0)
- Association analyses identify 31 new risk loci for colorectal cancer susceptibility (2019) (0)
- A microsatellite repeat in PCA3 long non-coding RNA is associated with prostate cancer risk and aggressiveness (2017) (0)
- Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemia (2019) (0)
- Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction (2021) (0)
- Prevalence of prostate specific antigen (PSA) testing by age group in Queensland males (2007) (0)
- GelMA and Biomimetic Culture Allow the Engineering of Mineralized, Adipose and Tumor Tissue Human Microenvironments for the Study of Advanced Prostate Cancer In Vitro and In Vivo. (2023) (0)
- Shared heritability and functional enrichment across six solid cancers (2019) (0)
- A Plasma Biomarker Panel of Four MicroRNAs for the Diagnosis of Prostate Cancer (2018) (0)
- Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility (2017) (0)
- Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (2018) (0)
- Genomic analysis of male puberty timing highlights shared genetic basis with hair colour and lifespan (2020) (0)
- Large-scale transcriptome-wide association study identifies new prostate cancer risk regions (2018) (0)
- Author Correction: Large-scale transcriptome-wide association study identifies new prostate cancer risk regions (2019) (0)
- A novel 3D prostate cancer bone marrow metastasis in vitro model system (2015) (0)
- Biochemical activity induced by a germline variation in KLK3 (PSA) associates with cellular function and clinical outcome in prostate cancer (2023) (0)
- Kallikrein-related peptidase 4 cleaves the Ephb4 tyrosine kinase receptor and its ligand, ephrinb2, to regulate epithelial cancer progression (2011) (0)
- Using high throughput microtissue culture to study the difference in prostate cancer cell behavior and drug response in 2D and 3D co-cultures (2018) (0)
- Integrating molecular, proteomic and vaccine development, quality of life and psychometric evaluations in a comprehensive research program (2004) (0)
- Author Correction: Germline variation at 8q24 and prostate cancer risk in men of European ancestry (2019) (0)
- Subject Index Vol. 47, 1988 (1988) (0)
- Kallikrein-related peptidase 15 (prostinogen) (2013) (0)
- Identification and characterization of a novel gene STAG1 is up-regulated in renal cell carcinoma (2001) (0)
- Author Correction: Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma (2019) (0)
- Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci (2019) (0)
- Free/total PSA ratios in ejaculate from trusbiopsy patients (1999) (0)
- Correction: Phenotypic Characterization of Prostate Cancer LNCaP Cells Cultured within a Bioengineered Microenvironment (2013) (0)
- Effects of autoclaving isoprenaline hydrochloride injections [proceedings]. (1979) (0)
- Title Tie-2 regulates the stemness and metastatic properties ofprostate cancer cells (2016) (0)
- The role of the kallikrein-kinn system in interstitial cystitis (1997) (0)
- Title: Integration of two in-depth quantitative proteomics approaches determines the kallikrein- related peptidase 7 (KLK7) degradome in ovarian cancer cell secretome. Authors and affiliations: (2018) (0)
This paper list is powered by the following services:
Other Resources About Judith Clements
What Schools Are Affiliated With Judith Clements?
Judith Clements is affiliated with the following schools:
